Section 1 Short title
This Act may be cited as the “Prohibiting Tianeptine and Other Dangerous Products Act of 2026”.
Prohibiting Tianeptine and Other Dangerous Products Act of 2026
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.
Sec. 2 New prohibited acts relating to dietary supplements
In general— Section 301 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331) is amended by adding at the end the following:
“(jjj) The introduction or delivery for introduction into interstate commerce of any product marketed as a dietary supplement that does not meet the definition of a dietary supplement under section 201(ff).
“(kkk) The introduction or delivery for introduction into interstate commerce of a dietary supplement that has been prepared, packed, or held using the assistance of, or at the direction of, a person debarred under section 306.”
New import exclusion— Section 801(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(a)) is amended in paragraph (3) of the third sentence, by striking “section 301(ll)” and inserting “paragraph (ll), (jjj), or (kkk) of section 301”.
New seizure authorities— Section 304 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 334) is amended—
in subsection (a)(1), in the first sentence, by striking “section section 301(ll), 404, or 505” and inserting “paragraph (ll), (jjj), or (kkk) of section 301, section 404, or section 505”; and
in subsection (d)(1), in the first sentence, by inserting “, or product in violation of paragraph (jjj) or (kkk) of section 301,” after “condemned under this section”.